Eli Lilly (LLY) FY22 Guidances Tops Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Eli Lilly (LLY) PT Raised to $320 at BMO Capital on Longer-Term Margin Expansion
December 16, 2021 8:43 AM ESTBMO Capital analyst Evan David Seigerman raised the price target on Eli Lilly (NYSE: LLY) to $320.00 (from $311.00) while maintaining an Outperform rating on higher margin optimism pos the Analyst Dal.
The analyst commented, "As Investor Day comes to an end, we are... More
